ancer cells often migrate from where the cancer initially formed, to colonize other parts of the body in a process called metastasis, which is associated with poor clinical prognosis. On page 215, Strilic et al. 1 uncover a surprising mechanism that migrating cancer cells in the bloodstream use to cross the lung's barrier of endothelial cells. The authors show that cancer cells send a signal that makes endothelial cells undergo a type of cell-death program called necroptosis (also known as programmed necrosis). Once in the lung, the cancer cells form lethal metastatic colonies.
The past three decades have provided increasing evidence that supports the key roles of endothelial cells in the formation and progression of tumours to a malignant state that has a poor prognosis for the patient [2] [3] [4] . Tumour cells rely heavily on the endothelial cells of blood vessels to enable continued tumour growth, because tumours need blood vessels to obtain oxygen and nutrients and expel metabolic waste.
Tumour cells exploit and manipulate endothelial cells by using intricate signalling mechanisms, such as those involving protein factors, secreted by tumours, that attract and remodel endothelial cells. Remodel ling of blood vessels by tumour-derived proteins can enable cancer cells that reside in the primary site of tumour growth to enter the blood circulation, providing an escape route for the cells to reach distant organs 5, 6 . After entering the bloodstream, cancer cells must cross the endothelial barriers that prevent them from entering other organs (Fig. 1a) . In certain tissues, such as the lung or brain, the interface between the tissue and the bloodstream is relatively impenetrable to tumour cells 6 . Strilic and colleagues' work began with an observation made when tumour cells and endothelial cells were cultured together in vitro. The researchers noted that such coculture leads to an increase in endothelialcell death. However, rather than exhibiting the typical cell-shape changes and molecular features of apoptosis, the most common form of programmed cell death, the dying endothelial cells exhibited features associated with another cell-death program called necroptosis. For example, the dying cells exhibited compromised cell-membrane integrity, as monitored by dye uptake.
To confirm the observed cell-death mechanism, the authors inhibited proteins that mediate necroptosis 7 , and found that this inhibited tumour-induced endothelial-cell death, whereas perturbing apoptotic signalling did not. They found that this necroptotic celldeath program was activated in both human and mouse endothelial cells exposed to a wide variety of cancer cell lines. Moreover, intravenous injection of mouse melanoma skincancer or lung-cancer cells into mice caused lung endothelial cells to undergo necroptotic death.
What advantage does killing endothelial cells afford tumour cells? Strilic and colleagues carried out in vitro experiments in which they inhibited necroptosis and observed reduced tumour-cell migration across an endothelialcell monolayer, leading the authors to propose and disease-related information. By doing so, we can begin to integrate multimodal data to understand how individual differences in brain organization can explain differences in function, behaviour and disorder. ■ 
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CANCER
Endothelial-cell killing promotes metastasis
To migrate into the lungs, cancer cells in the bloodstream must cross the lung's endothelial-cell barrier. A study shows that cancer cells can achieve this feat by signalling to induce endothelial-cell death. See Letter p.215 (Fig. 1b) . Consistent with this, pharmacological inhibition of DR6 signalling -achieved by injecting mice with a 'decoy' version of the DR6 receptor -inhibited metastasis.
Strilic et al. provide compelling evidence to support the existence of intricate signalling interactions between migrating tumour cells in the bloodstream and the blood-vessel endothelium that promote tumour-cell metastatic migration into tissue and subsequent tissue colonization. These findings raise a series of intriguing issues. Only a small fraction of endothelial cells cultured in vitro with tumour cells are induced to undergo necroptotic death. Discovering the molecular determinant that governs which endothelial cells die is a key challenge. The authors reveal that only approximately 10% of endothelial cells express DR6 and are thus susceptible to APP-mediated cell death.
It will be important to understand the mechanisms that regulate which fraction of endothelial cells express DR6, and whether cancer cells can regulate the susceptibility of endothelial cells to necroptosis by modulating DR6 expression on the cells. Microscopy analysis of human tumours could be used to reveal whether an increased
LY N N E C H A N T R A N U P O N G & DAV I D M . S A B AT I N I
T o maintain amino-acid and protein levels, cells must couple nutrient availability to protein synthesis and turnover. Central to this process is the enzyme called target of rapamycin complex 1 (TORC1) kinase, a master growth controller that integrates diverse environmental inputs to co ordinate many metabolic processes 1 . Rousseau and Bertolotti 2 reveal on page 184 that inhibition of TORC1 increases levels of the proteasome -a large protein complex involved in cellular protein degradation -to promote cell survival under stressful conditions. Consistent with previous reports [3] [4] [5] , the new work identifies TORC1 as a central regulator of proteasome homeostasis. However, the relationship between TORC1 and the control of proteasome function seems to be complex, because TORC1 can regulate the proteasome through multiple mechanisms that depend on the particular cellular context [3] [4] [5] .
The proteasome functions in one of the main protein-degradation pathways in cells, the ubi quitin-proteasome system 6 . In this pathway, a multi-enzymatic cascade co valently links the small polypeptide ubiquitin to proteins. This modification is recognized by the proteasome, which degrades ubiquitinated proteins to produce peptide mixtures that can then replenish the intracellular pool of amino acids 6 . The proteasome comprises a multisubunit core particle, which carries out protein degradation, and up to two additional regulatory particle components that facilitate substrate recognition, removal of ubiquitin, and protein unfolding and translocation into the proteasome 6 . Inhibition of the prot easome results in a lethal shortage of amino acids 7 ; therefore cells must maintain adequate proteasome levels to survive. However, the mechanisms that govern the assembly and regulation of this complex molecular machine, particularly under stressful conditions, are not fully understood.
The discovery 8 in yeast of Adc17, a stressinduced regulatory particle assembly chaperone protein (RAC), offers an insight into the mechanism of proteasome regulation.
CELL BIOLOGY
The TORC1 pathway to protein destruction A study of the proteasome -a protein-degradation complex -reveals an evolutionarily conserved pathway that acts through the protein kinase TORC1 to adjust proteasome levels in response to cellular needs. See Article p.184 fraction of DR6-expressing endothelial cells is associated with the propensity for lung metastatic progression. Perhaps molecular signals from the endothelium to tumour cells regulate expression or cleavage of APP on tumour cells -thus having an effect on endothelial-cell necroptosis. Such endothelial-cellderived signals have roles in epithelial-cell fate and function 9 . In addition to the mechanisms proposed by the authors, another mechanism by which endothelial-cell necroptosis might enhance tumour migration into tissue could be mediated by ATP. Release of ATP from dying endothelial cells might promote the survival of tumour cells during their migration through the endothelial barrier into the tissue 10 -a process that can cause traumatic tumour-cell deformation and death. Live-cell micro scopy imaging of tumour-and endothelial-cell dynamics during this interaction 11 may be an ideal means of determining which of the intriguing potential cellular mechanisms proposed by the authors might underlie 
